Brief: Abionyx Pharma End-March Cash Position Of EUR 5.9 Million

Abionyx Pharma SA

19/05/2022 17:26

May 19 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * Q1 CASH POSITION OF €5.9 MILLION AS OF MARCH 31, 2022
    * THE COMPANY CONTINUES TO RECEIVE NEW COMPASSIONATE ACCESS
AUTHORIZATION (CAA) REQUESTS FOR THE BIO-HDL (CER-001) FROM
SEVERAL HOSPITALS AROUND THE WORLD.
    * THE COMPANY WILL SOON COMMUNICATE ITS STRATEGY IN
OPHTHALMOLOGY
    * FINAL RESULTS OF THE STUDY CER-001 (RACERS) ARE EXPECTED
TO BE
AVAILABLE IN THE FALL OF 2022

Source text: https://bit.ly/380Taax
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))